Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market
Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.70% to $511.74 Monday, on what proved to be an all-around great trading ...
Jim Cramer on Vertex (VRTX): “A Revolutionary Anti-Pain Drug”
We recently published a list of Jim Cramer Discusses These 10 Stocks & Says US Faces Unfairly High Tariffs Abroad. In this ...
Vertex price target raised to $60 from $57 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Vertex (VERX) to $60 from $57 and keeps an Overweight rating on the shares. The company’s ...
Swiss National Bank Increases Holdings in Vertex, Inc. (NASDAQ:VERX)
Swiss National Bank raised its stake in Vertex, Inc. (NASDAQ:VERX – Free Report) by 7.3% during the 4th quarter, ...
Seeking Alpha2d
VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...